RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Roche Holding AG

A collection of news and information related to Roche Holding AG published by this site and its partners.

Top Roche Holding AG Articles see all

Displaying items 1-5
  • Weak Merck sales overshadow third-quarter cost cuts

    (Reuters) - Cost cuts enabled Merck & Co to beat third-quarter earnings forecasts but disappointing sales of its Gardasil cervical cancer vaccine and other big products sent its shares about 2 percent lower.
  • Database shows $3.5 billion in industry ties to doctors, hospitals

    Database shows $3.5 billion in industry ties to doctors, hospitals
    Pulling the curtain back on long-hidden industry relationships, the federal government revealed that U.S. doctors and teaching hospitals had $3.5 billion worth of financial ties with drug and medical-device makers in the last five months of 2013. The...

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

    Studies highlight treatment realities and promising new drugs

     Studies highlight treatment realities and promising new drugs
    234,000 number of Americans who will be diagnosed with breast cancer this year, according to the American Cancer Society. Men account for 2,240 cases. An estimated 40,000 will die from the disease. 55.9% of black women on Medicare who were told they...

    New cancer tools allow patients to reconsider chemo

    New cancer tools allow patients to reconsider chemo
    LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...